Zobrazeno 1 - 10
of 130
pro vyhledávání: '"Jennifer K, Plichta"'
Autor:
Huiyue Li, Yun Wu, Haotian Zou, Salil Koner, Jennifer K. Plichta, Sara M. Tolaney, Jian Zhang, You-Wen He, Qingyi Wei, Li Tang, Hui Zhang, Baoshan Zhang, Yuanyuan Guo, Xin Chen, Kan Li, Liyou Lian, Fei Ma, Sheng Luo
Publikováno v:
EBioMedicine, Vol 105, Iss , Pp 105186- (2024)
Summary: Background: Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in combination with traditional endocrine therapy (ET) are now the recommended first-line treatment for hormone receptor (HR)-positive and HER2-negative metastatic breast cancer (MB
Externí odkaz:
https://doaj.org/article/a88a4058f89f47909933524af7e014a0
Autor:
Ipshita Prakash, N. Ben Neely, Samantha M. Thomas, Sarah Sammons, Rachel C. Blitzblau, Gayle A. DiLalla, Terry Hyslop, Carolyn S. Menendez, Jennifer K. Plichta, Laura H. Rosenberger, Oluwadamilola M. Fayanju, E. Shelley Hwang, Rachel A. Greenup
Publikováno v:
Cancer Medicine, Vol 11, Iss 4, Pp 1099-1108 (2022)
Abstract Background Controversy exists regarding the optimal sequence of chemotherapy among women with operable node‐negative breast cancers with high‐risk tumor biology. We evaluated national patterns of neoadjuvant chemotherapy (NACT) use among
Externí odkaz:
https://doaj.org/article/17bacb17c23f4bb29164cca8bf68449c
Autor:
Sydney M. Record, Tori Chanenchuk, Kendra M. Parrish, Samantha J. Kaplan, Gretchen Kimmick, Jennifer K. Plichta
Publikováno v:
Medicina, Vol 59, Iss 9, p 1576 (2023)
Background: Breast cancer is the most common cancer in women, and older patients comprise an increasing proportion of patients with this disease. The older breast cancer population is heterogenous with unique factors affecting clinical decision makin
Externí odkaz:
https://doaj.org/article/f434ff1460be4b7e971e0268e8d7f826
Autor:
Jennifer K. Plichta, Samantha M. Thomas, Daniel F. Hayes, Mariana Chavez-MacGregor, Kimberly Allison, Jennifer de los Santos, Amy M. Fowler, Armando E. Giuliano, Priyanka Sharma, Benjamin D. Smith, Elizabeth van Eycken, Stephen B. Edge, Gabriel N. Hortobagyi
Publikováno v:
Journal of Clinical Oncology. 41:2546-2560
PURPOSE Given the heterogeneity and improvement in outcomes for metastatic breast cancer (MBC), we developed a staging system that refines prognostic estimates for patients with metastatic cancer at the time of initial diagnosis, de novo MBC (dnMBC),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b65c2307af6cb35eb79b0b3e5f8c369e
https://doi.org/10.1200/jco.22.02222
https://doi.org/10.1200/jco.22.02222
Autor:
Hannah E. Woriax, Samantha M. Thomas, Jennifer K. Plichta, Laura H. Rosenberger, Astrid Botty van de bruele, Akiko Chiba, Gayle DiLalla, Carolyn Menendez, E Shelley Hwang, Maggie L. DiNome
Publikováno v:
Cancer Research. 83:P1-06
Introduction: Despite the recent overall improvement in survival for patients with breast cancer, racial disparities in outcomes persist. While studies have demonstrated that socioeconomic factors and access to treatment play a role, differences in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09ef734d0b4eac92e930c3bf2f09ab07
https://doi.org/10.1158/1538-7445.sabcs22-p1-06-02
https://doi.org/10.1158/1538-7445.sabcs22-p1-06-02
Publikováno v:
Surgical Clinics of North America. 103:35-47
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26bd3768d7d4f397faeba28ac98db667
https://doi.org/10.1016/j.suc.2022.08.016
https://doi.org/10.1016/j.suc.2022.08.016
Publikováno v:
Current Breast Cancer Reports. 15:37-47
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a36c70e5ce342c11649359bef283ed7a
https://doi.org/10.1007/s12609-023-00476-4
https://doi.org/10.1007/s12609-023-00476-4
Autor:
Astrid Botty van den Bruele, Morgan Paul, Samantha M. Thomas, Sarah L. Sammons, Maggie L. DiNome, Jennifer K. Plichta, Akiko Chiba, Laura H. Rosenberger, E Shelley Hwang
Publikováno v:
Cancer Research. 83:P3-05
Background: The predictive and prognostic value of the 21-gene recurrence score (RS) has emphasized the importance of tumor biology and minimized the credence of a limited (1-3 positive) nodal burden. The practice changing results of RxPonder demonst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::932a5c2e79798c1fe1cf7726815bb2ae
https://doi.org/10.1158/1538-7445.sabcs22-p3-05-20
https://doi.org/10.1158/1538-7445.sabcs22-p3-05-20
Autor:
Jennifer K. Plichta, Christel N. Rushing, Holly C. Lewis, Marguerite M. Rooney, Dan G. Blazer, Samantha M. Thomas, E. Shelley Hwang, Rachel A. Greenup
Publikováno v:
Breast Cancer Research and Treatment. 197:177-187
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d34505dd3847e7e9f4278a62cd7214c8
https://doi.org/10.1007/s10549-022-06764-4
https://doi.org/10.1007/s10549-022-06764-4
Autor:
Krislyn N. Miller, Samantha M. Thomas, Amanda R. Sergesketter, Laura H. Rosenberger, Gayle DiLalla, Astrid Botty van den Bruele, E. Shelley Hwang, Jennifer K. Plichta
Publikováno v:
Annals of Surgical Oncology. 29:6484-6494
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89e7d34fe8666496d948688589aeed16
https://doi.org/10.1245/s10434-022-12313-6
https://doi.org/10.1245/s10434-022-12313-6